The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in venture capital, biological age testing has moved from academic curiosity to ...
Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.
The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV ...
In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine ...
Researchers developed a nasal vaccine that provides broad protection against respiratory viruses, bacteria, and allergens in ...
THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
Last week, one person in Bengal died of complications related to the virus. Here’s a lowdown on its origin and deadly impact ...
A 91-year-old man was admitted to the hospital with weight loss, dyspnea, and eosinophilia. An anteroposterior chest radiograph obtained 2 months earlier showed bibasilar patchy opacities. A ...
First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
The U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot.